Fulvestrant Export Market Intelligence: India's 84 Suppliers Shipping to 66 Countries — TransData Nexus 2026

Q: Who are the top fulvestrant exporters from India?

The top fulvestrant exporters from India are: 1. INTAS PHARMACEUTICALS LIMITED — $4.4M (30.3% market share); 2. JODAS EXPOIM PRIVATE LIMITED — $1.8M (12.2% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $1.7M (11.4% market share); 4. DR REDDYS LABORATORIES LIMITED — $1.7M (11.3% market share); 5. ALEMBIC PHARMACEUTICALS LIMITED — $1.5M (9.9% market share). Together they account for 75.2% of India's total fulvestrant export value.

Q: What is the total export value of fulvestrant from India?

The total export value of fulvestrant from India is $14.6M USD, recorded across 487 shipment transactions from 84 active exporters to 66 destination countries. The average shipment value is $30.0K.

Q: Which countries import fulvestrant from India?

India exports fulvestrant to 66 countries worldwide. The top importing countries are: UNITED STATES (30.0% share, $4.4M), BELGIUM (10.2% share, $1.5M), ITALY (8.3% share, $1.2M), NETHERLANDS (6.8% share, $989.4K), RUSSIA (6.7% share, $981.1K). These five markets account for 62.0% of total export value.

Q: What is the HS code for fulvestrant exports from India?

The primary HS code for fulvestrant exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of fulvestrant exports from India?

The average unit price for fulvestrant exports from India is $45.94 USD per unit, with prices ranging from $0.02 to $647.00 depending on formulation, packaging, and order volume. The total market is valued at $14.6M across 487 shipments.

Q: Which ports handle fulvestrant exports from India?

The primary ports for fulvestrant exports from India are SAHAR AIR (20.1% of shipments), AHEMDABAD AIR ACC (INAMD4) (14.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.5% of shipments), Bombay Air (6.8% of shipments), MUNDRA SEA (INMUN1) (4.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of fulvestrant?

India is one of the world's leading exporters of fulvestrant due to its large base of 84 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports fulvestrant to 66 countries, demonstrating 34% global market coverage.

Q: What certifications do Indian fulvestrant exporters need?

Indian fulvestrant exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import fulvestrant from India?

There are 148 registered buyers importing fulvestrant from India, spread across 66 countries. The repeat buyer rate is 45.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top fulvestrant supplier from India?

INTAS PHARMACEUTICALS LIMITED is the leading fulvestrant exporter from India with a market share of 30.3% and total export value of $4.4M across 160 shipments. The top 5 suppliers together control 75.2% of total export value.

Suresh Sormare

Fulvestrant

India Pharmaceutical Trade Intelligence

$14.6M84 Suppliers66 CountriesHS 30049049

ExportsIndia → UNITED STATES30.0%India → BELGIUM10.2%

ImportsGERMANY → India$949.4K UNITED KINGDOM → India$335.9K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: YUSEN LOGISTICS

Fulvestrant Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Fulvestrant to the World

Between 2022 and 2026, India exported $14.6M worth of fulvestrant across 487 verified shipments to 66 countries — covering 34% of world markets in the Advanced Oncology segment. The largest destination is UNITED STATES (30.0%). INTAS PHARMACEUTICALS LIMITED leads with a 30.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Fulvestrant export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Fulvestrant export data snapshot — $14.6M · 84 exporters · 66 countriesTransData Nexus · Indian Customs Data

Top Fulvestrant Exporters from India

84 active exporters · Ranked by export value

View all 84 →

Top Fulvestrant Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INTAS PHARMACEUTICALS LIMITED	$4.4M	160	11	30.3%
2	JODAS EXPOIM PRIVATE LIMITED

Top Countries Importing Fulvestrant from India

66 destination markets · Ranked by import value

All 66 countries →

Top Countries Importing Fulvestrant from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$4.4M	30.0%
2	BELGIUM	$1.5M	10.2%
3	ITALY	$1.2M	8.3%
4	NETHERLANDS	$989.4K	6.8%
5	RUSSIA	$981.1K	6.7%
6	BRAZIL	$955.9K	6.5%
7	SPAIN	$829.9K	5.7%
8	SRI LANKA	$804.6K	5.5%
9	POLAND	$564.2K	3.9%
10	MALTA	$496.3K	3.4%

UNITED STATES is India's largest fulvestrant export destination, absorbing 30.0% of total exports worth $4.4M. The top 5 importing countries — UNITED STATES, BELGIUM, ITALY, NETHERLANDS, RUSSIA — together account for 62.0% of India's total fulvestrant export value. The remaining 61 destination countries collectively receive the other 38.0%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Fulvestrant to India?

9 origin countries · Total import value: $1.7M

India imports fulvestrant from 9 countries with a combined import value of $1.7M. The largest supplier is GERMANY ($949.4K, 4 shipments), followed by UNITED KINGDOM and ITALY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Fulvestrant to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$949.4K	4	56.4%
2	UNITED KINGDOM	$335.9K	3	20.0%
3	ITALY	$265.4K	2	15.8%
4	UNITED STATES	$106.3K	10	6.3%
5	BULGARIA	$15.7K	3	0.9%
6	AUSTRALIA	$5.6K	3	0.3%
7	JAPAN	$2.2K	1	0.1%
8	SOUTH AFRICA	$1.8K	1	0.1%
9	NETHERLANDS	$896	2	0.1%

GERMANY is the largest supplier of fulvestrant to India, accounting for 56.4% of total import value. The top 5 origin countries — GERMANY, UNITED KINGDOM, ITALY, UNITED STATES, BULGARIA — together supply 99.4% of India's fulvestrant imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Fulvestrant

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, the Food and Drug Administration (FDA) has approved multiple Abbreviated New Drug Applications (ANDAs) for fulvestrant, facilitating the availability of generic versions. For instance, Amneal Pharmaceuticals received approval for their ANDA 210044 on May 30, 2018, for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per syringe. The regulatory pathway for fulvestrant involves demonstrating bioequivalence to the reference listed drug, Faslodex, originally approved on April 25, 2002.

The presence of 84 active Indian exporters supplying fulvestrant to the U.S. market reflects a robust competitive landscape. This diversity ensures a steady supply chain, contributing to market stability and potentially influencing pricing dynamics.

2EU & UK Regulatory Framework

Within the European Union, fulvestrant has been authorized for use in treating estrogen receptor-positive, locally advanced or metastatic breast cancer. The European Medicines Agency (EMA) granted marketing authorization for Fulvestrant Mylan on January 8, 2018, as a generic equivalent to Faslodex. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, ensuring consistent regulatory oversight.

Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting to these regions. This includes adherence to stringent quality control measures and regular inspections to maintain product integrity and patient safety.

3WHO Essential Medicines & Global Standards

Fulvestrant is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. This inclusion mandates adherence to international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, fulvestrant is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) oversees its pricing to ensure affordability. Exporters are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) prior to exporting pharmaceuticals, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for fulvestrant have expired, leading to increased generic competition. This has resulted in a more competitive market landscape, with multiple manufacturers offering generic versions, thereby enhancing accessibility and affordability for patients worldwide.

6Recent Industry Developments

In June 2024, the EMA granted marketing authorization for Truqap (capivasertib) in combination with fulvestrant for the treatment of certain types of breast cancer, expanding therapeutic options for patients. (ema.europa.eu)

In November 2025, the EMA renewed the marketing authorization for Fulvestrant Mylan, affirming its continued safety and efficacy in the European market. (ema.europa.eu)

These developments reflect the dynamic nature of the pharmaceutical industry, with ongoing regulatory activities and market entries influencing the global availability and utilization of fulvestrant.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Fulvestrant

Retail & reference prices across 9 markets vs. India FOB export price of $45.94/unit

Global Price Benchmark for Fulvestrant across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1,200	USD	According to the FDA's Orange Book, Fulvestrant is approved for use in the United States.
United Kingdom	$1,040	GBP	As per the NHS Drug Tariff, Fulvestrant is listed for use within the National Health Service.
Germany	$1,045	EUR	The European Medicines Agency (EMA) has authorized the use of Fulvestrant in Germany.
Australia	$1,125	AUD

Supply Chain Risk Assessment — Fulvestrant

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on imported Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), with approximately 70% sourced from China. This dependency exposes the supply chain to risks such as geopolitical tensions, trade restrictions, and production disruptions in China. For instance, regulatory overhauls in China have previously led to production halts, affecting global API availability.

To mitigate these risks, the Indian government launched the Production Linked Incentive (PLI) scheme for bulk drugs, aiming to bolster domestic API and KSM manufacturing. By March 2025, this initiative resulted in import savings of ₹1,362 crore and established domestic production capacity for 25 critical APIs. However, fulvestrant's API and KSMs were not among the initial focus areas, indicating continued reliance on imports for its production.

2Supplier Concentration & Single-Source Risk

The export market for fulvestrant from India is notably concentrated. The top five exporters—Intas Pharmaceuticals Limited (30.3% share), Jodas Expoim Private Limited (12.2%), Sun Pharmaceutical Industries Limited (11.4%), Dr. Reddy's Laboratories Limited (11.3%), and Alembic Pharmaceuticals Limited (9.9%)—collectively account for 75.2% of total exports. This high concentration poses a risk; disruptions at any of these key suppliers could significantly impact global supply.

Access Complete Fulvestrant Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 487 transactions across 66 markets.

Request Demo View Pricing

Frequently Asked Questions — Fulvestrant Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top fulvestrant exporters from India?

The leading fulvestrant exporters from India are INTAS PHARMACEUTICALS LIMITED, JODAS EXPOIM PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 8 others. INTAS PHARMACEUTICALS LIMITED leads with 30.3% market share ($4.4M). The top 5 suppliers together control 75.2% of total export value.

What is the total export value of fulvestrant from India?

The total export value of fulvestrant from India is $14.6M, recorded across 487 shipments from 84 active exporters to 66 countries. The average shipment value is $30.0K.

Which countries import fulvestrant from India?

India exports fulvestrant to 66 countries. The top importing countries are UNITED STATES (30.0%), BELGIUM (10.2%), ITALY (8.3%), NETHERLANDS (6.8%), RUSSIA (6.7%), which together account for 62.0% of total export value.

What is the HS code for fulvestrant exports from India?

The primary HS code for fulvestrant exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fulvestrant

Fulvestrant

Top Fulvestrant Exporters from India

Top Countries Importing Fulvestrant from India

Who Supplies Fulvestrant to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Fulvestrant

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Fulvestrant

Supply Chain Risk Assessment — Fulvestrant

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Fulvestrant Trade Intelligence

Frequently Asked Questions — Fulvestrant Exports from India

Who are the top fulvestrant exporters from India?

What is the total export value of fulvestrant from India?

Which countries import fulvestrant from India?

What is the HS code for fulvestrant exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of fulvestrant exports from India?

Which ports handle fulvestrant exports from India?

Why is India a leading exporter of fulvestrant?

What certifications do Indian fulvestrant exporters need?

How many buyers import fulvestrant from India?

What is the market share of the top fulvestrant exporter from India?

Analysis Methodology